Related Experiment Videos
New colorimetric cytotoxicity assay for anticancer-drug screening
P Skehan1, R Storeng, D Scudiero
1Division of Cancer Treatment, National Cancer Institute, Frederick, MD 21701.
Journal of the National Cancer Institute
|July 4, 1990
Summary
A new sulforhodamine B (SRB) assay offers a rapid, sensitive, and inexpensive method for measuring cellular protein in cell cultures. This cost-effective assay is ideal for large-scale drug discovery screening and cytotoxicity testing.
Area of Science:
- Biochemistry
- Cell Biology
- Drug Discovery
Background:
- Accurate measurement of cellular protein is crucial for assessing cell viability and drug efficacy.
- Existing protein assays can be time-consuming, expensive, or lack sensitivity for high-throughput screening.
Purpose of the Study:
- To develop and validate a rapid, sensitive, and inexpensive method for quantifying cellular protein content.
- To establish an assay suitable for both standard laboratory use and large-scale drug screening applications.
Main Methods:
- Utilized sulforhodamine B (SRB) staining of trichloroacetic acid-fixed cells in 96-well microtiter plates.
- Measured protein-bound SRB dye via optical density using a microtiter plate reader.
- Compared SRB assay results with Lowry and Bradford protein assays and fluorescence-based methods.
Main Results:
- The SRB assay demonstrated linearity with cell number and protein content across a wide density range.
- Achieved a signal-to-noise ratio of approximately 1.5 with as few as 1,000 cells per well.
- SRB assay sensitivity was superior to Lowry, Bradford, and 20 other visible dyes, and comparable to fluorescence assays.
Conclusions:
- The SRB assay is a robust, cost-effective, and sensitive method for measuring cellular protein.
- Its suitability for high-volume, automated screening makes it valuable for drug discovery and cytotoxicity assessment.
- The assay provides a stable, visible endpoint and can be used for clonogenicity and single-cell analysis.